Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
19.23
+0.54 (2.89%)
Nov 2, 2026, 4:00 PM EST - Market closed
Faeth Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 | Buy | Reiterates | $60 | +212.01% | Oct 27, 2026 |
| BTIG | BTIG | Buy Reiterates $55 | Buy | Reiterates | $55 | +186.01% | Oct 27, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $70 | Buy | Maintains | $70 | +264.01% | Oct 27, 2026 |
| Citi | Citi | Buy Maintains $55 | Buy | Maintains | $55 | +186.01% | Oct 16, 2026 |
| William Blair | William Blair | Buy Initiates $66 | Buy | Initiates | $66 | +243.21% | Oct 16, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Initiates $40 | Buy | Initiates | $40 | +108.01% | Oct 15, 2026 |
| Lucid Capital | Lucid Capital | Buy Initiates $59 | Buy | Initiates | $59 | +206.81% | Sep 14, 2026 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Sep 9, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.